Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.

Namdar A, Nikbin B, Ghabaee M, Bayati A, Izad M.

J Neuroimmunol. 2010 Jan 25;218(1-2):120-4. doi: 10.1016/j.jneuroim.2009.10.013. Epub 2009 Nov 22.

PMID:
19932513
2.

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.

Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, D'hooghe MB, Dubois B, Raus J, Stinissen P.

J Neurosci Res. 2006 Jun;83(8):1432-46.

PMID:
16583400
3.

Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B.

Arch Neurol. 2008 Nov;65(11):1434-9. doi: 10.1001/archneur.65.11.1434.

PMID:
19001161
4.

Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients.

Frisullo G, Nociti V, Iorio R, Patanella AK, Caggiula M, Marti A, Sancricca C, Angelucci F, Mirabella M, Tonali PA, Batocchi AP.

Immunology. 2009 Jul;127(3):418-28. doi: 10.1111/j.1365-2567.2008.02963.x. Epub 2008 Nov 7.

5.
6.

Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.

Cosentino M, Zaffaroni M, Trojano M, Giorelli M, Pica C, Rasini E, Bombelli R, Ferrari M, Ghezzi A, Comi G, Livrea P, Lecchini S, Marino F.

Neuroimmunomodulation. 2012;19(5):283-92. doi: 10.1159/000336981. Epub 2012 Apr 3.

PMID:
22472872
7.

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.

Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F.

Mult Scler. 2008 Jun;14(5):622-30. doi: 10.1177/1352458507087136. Epub 2008 Apr 18.

PMID:
18424480
8.

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.

de Andrés C, Aristimuño C, de Las Heras V, Martínez-Ginés ML, Bartolomé M, Arroyo R, Navarro J, Giménez-Roldán S, Fernández-Cruz E, Sánchez-Ramón S.

J Neuroimmunol. 2007 Jan;182(1-2):204-11. Epub 2006 Dec 8.

PMID:
17157927
9.

Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.

Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.

J Neurol Sci. 2004 Jul 15;222(1-2):65-73.

PMID:
15240198
10.

Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.

de Andrés C, Aristimuño C, Bartolomé M, de Las Heras V, Martínez-Ginés ML, Arroyo R, Fernández-Cruz E, Sánchez-Ramón S.

J Neuroimmunol. 2009 Jul 25;212(1-2):112-20. doi: 10.1016/j.jneuroim.2009.04.009. Epub 2009 May 15.

PMID:
19446889
11.

CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.

Saresella M, Marventano I, Longhi R, Lissoni F, Trabattoni D, Mendozzi L, Caputo D, Clerici M.

FASEB J. 2008 Oct;22(10):3500-8. doi: 10.1096/fj.08-110650. Epub 2008 Jun 27.

PMID:
18587005
12.

CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.

McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN, Stewart GJ, Booth DR.

J Autoimmun. 2008 Aug;31(1):52-8. doi: 10.1016/j.jaut.2008.02.003. Epub 2008 Apr 11.

PMID:
18406576
13.

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.

Scand J Immunol. 2006 Aug;64(2):155-63.

14.

Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.

Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C, Renoldi G, Parma M, Balduzzi A, Perseghin P, Biondi A.

Transplantation. 2007 Jul 15;84(1):31-9.

PMID:
17627234
15.

Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.

Vandenbark AA, Huan J, Agotsch M, La Tocha D, Goelz S, Offner H, Lanker S, Bourdette D.

J Neuroimmunol. 2009 Oct 30;215(1-2):125-8. doi: 10.1016/j.jneuroim.2009.08.007. Epub 2009 Sep 15.

PMID:
19758707
16.

Association between parasite infection and immune responses in multiple sclerosis.

Correale J, Farez M.

Ann Neurol. 2007 Feb;61(2):97-108.

PMID:
17230481
17.

IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.

Aristimuño C, de Andrés C, Bartolomé M, de las Heras V, Martínez-Ginés ML, Arroyo R, Fernández-Cruz E, Sánchez-Ramón S.

Clin Immunol. 2010 Feb;134(2):148-57. doi: 10.1016/j.clim.2009.09.008. Epub 2009 Nov 8.

PMID:
19900844
18.

A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H.

Laryngoscope. 2007 May;117(5):876-80.

PMID:
17473687
19.

CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.

Frisullo G, Nociti V, Iorio R, Plantone D, Patanella AK, Tonali PA, Batocchi AP.

Hum Immunol. 2010 May;71(5):437-41. doi: 10.1016/j.humimm.2010.01.024. Epub 2010 Feb 14.

PMID:
20138197
20.

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A.

J Neuroimmunol. 2011 Mar;232(1-2):171-8. doi: 10.1016/j.jneuroim.2010.10.007. Epub 2010 Nov 26.

PMID:
21111488

Supplemental Content

Support Center